- Home
- Publications
- Publication Search
- Publication Details
Title
Progress in HIV vaccine development
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 13, Issue 5, Pages 1018-1030
Publisher
Informa UK Limited
Online
2017-03-10
DOI
10.1080/21645515.2016.1276138
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention
- (2016) Lindsey R. Baden et al. ANNALS OF INTERNAL MEDICINE
- Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
- (2016) Dennis R. Burton et al. Annual Review of Immunology
- Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design
- (2016) Saheli Sadanand et al. Annual Review of Medicine
- Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
- (2016) Bryan Briney et al. CELL
- New concepts in HIV-1 vaccine development
- (2016) Kathryn E Stephenson et al. CURRENT OPINION IN IMMUNOLOGY
- Viral vectors as vaccine platforms: from immunogenicity to impact
- (2016) Katie J Ewer et al. CURRENT OPINION IN IMMUNOLOGY
- An HIV Vaccine
- (2016) Anthony S. Fauci JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial
- (2016) Sheena McCormack et al. LANCET
- Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16
- (2016) B M Gunn et al. Mucosal Immunology
- A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
- (2016) Rajeev Gautam et al. NATURE
- International AIDS Society global scientific strategy: towards an HIV cure 2016
- (2016) Steven G Deeks et al. NATURE MEDICINE
- Antiretroviral Therapy for the Prevention of HIV-1 Transmission
- (2016) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low- and Middle-Income Countries
- (2016) Thomas M. Harmon et al. PLoS One
- HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
- (2016) J. G. Jardine et al. SCIENCE
- Sustained virologic control in SIV+ macaques after antiretroviral and 4 7 antibody therapy
- (2016) S. N. Byrareddy et al. SCIENCE
- Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus
- (2016) Jinyan Liu et al. SCIENCE
- Status of vaccine research and development of vaccines for HIV-1
- (2016) Jeffrey T. Safrit et al. VACCINE
- Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
- (2016) Linling He et al. Nature Communications
- Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability
- (2016) Leopold Kong et al. Nature Communications
- Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
- (2016) Elise Landais et al. PLoS Pathogens
- Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses
- (2016) Matthew Zirui Tay et al. PLoS Pathogens
- Broadly Neutralizing Antibodies for HIV Eradication
- (2016) Kathryn E. Stephenson et al. Current HIV/AIDS Reports
- Adenovirus vectors as HIV-1 vaccines
- (2015) Marie Patricia DʼSouza et al. AIDS
- Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection
- (2015) Jerome H. Kim et al. Annual Review of Medicine
- Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
- (2015) J. E. Ledgerwood et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Choice of Antiretroviral Drugs for Postexposure Prophylaxis for Adults and Adolescents: A Systematic Review
- (2015) N. Ford et al. CLINICAL INFECTIOUS DISEASES
- Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
- (2015) J. G. Jardine et al. SCIENCE
- HIV-1 neutralizing antibodies induced by native-like envelope trimers
- (2015) R. W. Sanders et al. SCIENCE
- Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
- (2015) D. H. Barouch et al. SCIENCE
- Immune correlates of vaccine protection against HIV-1 acquisition
- (2015) Lawrence Corey et al. Science Translational Medicine
- Letter to the Editor on: The RV144 vaccine regimen was not associated with enhancement of infection
- (2015) Sandhya Vasan et al. Human Vaccines & Immunotherapeutics
- HIV Vaccine Efficacy and Immune Correlates of Risk
- (2014) Robert O'Connell et al. CURRENT HIV RESEARCH
- Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
- (2014) Masashi Shingai et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo
- (2014) R. S. Rudicell et al. JOURNAL OF VIROLOGY
- Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
- (2014) Alejandro B Balazs et al. NATURE MEDICINE
- Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection
- (2014) Siddappa N Byrareddy et al. NATURE MEDICINE
- Novel vaccine vectors for HIV-1
- (2014) Dan H. Barouch et al. NATURE REVIEWS MICROBIOLOGY
- Ending AIDS — Is an HIV Vaccine Necessary?
- (2014) Anthony S. Fauci et al. NEW ENGLAND JOURNAL OF MEDICINE
- A critical question for HIV vaccine development: Which antibodies to induce?
- (2014) S. Zolla-Pazner SCIENCE
- Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
- (2014) A. W. Chung et al. Science Translational Medicine
- Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor
- (2014) A. Pegu et al. Science Translational Medicine
- Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
- (2014) N. L. Yates et al. Science Translational Medicine
- Which Antibody Functions are Important for an HIV Vaccine?
- (2014) Bin Su et al. Frontiers in Immunology
- Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
- (2013) Peter Hraber et al. AIDS
- In Pursuit of an HIV Vaccine: Designing Efficacy Trials in the Context of Partially Effective Nonvaccine Prevention Modalities
- (2013) Holly Janes et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
- (2013) Dan H. Barouch et al. CELL
- Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
- (2013) Hua-Xin Liao et al. IMMUNITY
- Infectious Virion Capture by HIV-1 gp120-Specific IgG from RV144 Vaccinees
- (2013) P. Liu et al. JOURNAL OF VIROLOGY
- Immune clearance of highly pathogenic SIV infection
- (2013) Scott G. Hansen et al. NATURE
- Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
- (2013) Scott M. Hammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
- (2013) Susan Zolla-Pazner et al. PLoS One
- Differential Binding of IgG and IgA to Mucus of the Female Reproductive Tract
- (2013) Kelly M. Fahrbach et al. PLoS One
- Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
- (2013) G. D. Tomaras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New paradigms for functional HIV-specific nonneutralizing antibodies
- (2013) Don Forthal et al. Current Opinion in HIV and AIDS
- A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
- (2013) Rogier W. Sanders et al. PLoS Pathogens
- A Blueprint for HIV Vaccine Discovery
- (2012) Dennis R. Burton et al. Cell Host & Microbe
- First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)
- (2012) Lindsey R. Baden et al. JOURNAL OF INFECTIOUS DISEASES
- Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)
- (2012) A. Duerr et al. JOURNAL OF INFECTIOUS DISEASES
- Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
- (2012) D. C. Montefiori et al. JOURNAL OF INFECTIOUS DISEASES
- Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001)
- (2012) Dan H. Barouch et al. JOURNAL OF INFECTIOUS DISEASES
- Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144
- (2012) Merlin L Robb et al. LANCET INFECTIOUS DISEASES
- Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
- (2012) Morgane Rolland et al. NATURE
- B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
- (2012) Barton F Haynes et al. NATURE BIOTECHNOLOGY
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
- (2012) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults
- (2012) Michael C. Keefer et al. PLoS One
- Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
- (2012) B. Moldt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune markers and correlates of protection for vaccine induced immune responses
- (2012) Aneesh Thakur et al. VACCINE
- The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection
- (2011) E. S. Gray et al. JOURNAL OF VIROLOGY
- Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
- (2011) Glenda E Gray et al. LANCET INFECTIOUS DISEASES
- Antibody-based protection against HIV infection by vectored immunoprophylaxis
- (2011) Alejandro B. Balazs et al. NATURE
- Broad neutralization coverage of HIV by multiple highly potent antibodies
- (2011) Laura M. Walker et al. NATURE
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
- (2011) Scott G. Hansen et al. NATURE
- Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
- (2011) Morgane Rolland et al. NATURE MEDICINE
- HIV Vaccine Development — Improving on Natural Immunity
- (2011) Margaret I. Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention of HIV-1 Infection with Early Antiretroviral Therapy
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
- (2011) J. F. Scheid et al. SCIENCE
- International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
- (2011) Dan H. Barouch et al. VACCINE
- Challenges in the Design of HIV Prevention Trials in the United States
- (2010) Deborah Donnell et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
- (2010) Dan H Barouch et al. NATURE MEDICINE
- Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
- (2010) Sampa Santra et al. NATURE MEDICINE
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heterologous prime–boost vaccination
- (2009) Shan Lu CURRENT OPINION IN IMMUNOLOGY
- Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm
- (2009) M. D. Simek et al. JOURNAL OF VIROLOGY
- Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
- (2009) Philip R Johnson et al. NATURE MEDICINE
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1
- (2009) A. Benlahrech et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
- Frequency and Phenotype of Human Immunodeficiency Virus Envelope-Specific B Cells from Patients with Broadly Cross-Neutralizing Antibodies
- (2008) N. A. Doria-Rose et al. JOURNAL OF VIROLOGY
- Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection
- (2008) D. N. Sather et al. JOURNAL OF VIROLOGY
- HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control
- (2008) B. Emu et al. JOURNAL OF VIROLOGY
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
- (2008) M Juliana McElrath et al. LANCET
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started